Ajay Goel, Ph.D., M.S. Researchers led by Ajay Goel, Ph.D., M.S., founding chair of the Department of Molecular Diagnostics and Experimental Therapeutics and founding director of Biotech Innovations at Beckman Research Institute...

City of Hope scientists are devoted to unraveling the cellular intricacies of how diabetes occurs and developing leading-edge therapies.   At the recent 81st Scientific Sessions of the American Diabetes...

The need for innovative science to address type 1 diabetes only grows more urgent. The JDRF counts 1.6 million people living with the disease in the U.S., and that number is increasing...

Jodi Cruz never expected to be this healthy, or this lucky, or possibly even alive, by now.   That’s because the 45-year-old mother of three from Irvine, California, had struggled...

Biochemist Charles Brenner, Ph.D., has joined City of Hope to lead the nation’s first research department focused on the intersection between cancer and diabetes. He is also the inaugural holder...

A targeted therapy for colorectal cancer and an immunotherapy drug for head and neck cancer are just some of the innovative treatments City of Hope doctors presented at this year’s...

James Lacey Jr., Ph.D., M.P.H. A $12 million federal grant awarded in 2016 enabled City of Hope and collaborators to deploy a novel cloud-computing platform, making an immense amount of...

In order for cancer to form in the human body, normal cells must acquire multiple mutations before they develop toward the disease. It was previously believed that these mutations acted...

The Epstein-Barr virus (EBV) is best known for causing mononucleosis, or “mono,” but it is also linked to several types of cancer, including lymphomas and carcinomas. With more than 90%...

Energy, passion and a unique talent for both surgery and science have launched a notable medical career for Mustafa Raoof, M.D., M.S., a surgical oncologist and researcher specializing in gastrointestinal...